We’re a diverse blend of solution-focused geneticists, biologists, clinicians, and so much more. Our deep experience in multiple disease areas and technologies produces a cross-pollination of ideas for new medicines to meet the needs of patients whose genetics place them at high-risk and who have no therapeutic options.
We embrace achievement and herald all our colleagues’ participation and collaboration. We build new views on existing questions and hold dear that we are accountable to one another so that we can develop better therapies for people. We welcome new ideas that spring from interaction and recognize this is a potent source of innovation.